Ver Financiación - Prisma - Unidad de Bibliometría

Sistemas químicos para la vectorización y liberación selectiva de nuevos inhibidores enzimáticos citotóxicos

Referencia: PID2020-116460RB-I00

Tipo: Proyecto de investigación
Programa financiador: Plan Estatal 2017-2020 Retos - Proyectos I+D+i
Entidad financiadora: Ministerio de Ciencia e Innovación
Ámbito: Nacional
Convocatoria competitiva:
Fecha de inicio: 01/09/2021
Fecha de fin: 31/08/2024
Participantes en la financiación
Nombre Rol
Moreno Vargas, Antonio José Responsable
López López, Óscar Responsable
Fernández-Bolaños Guzmán, José María Investigador/a
Robina Ramírez, Inmaculada Investigador/a
Maya Castilla, Inés Investigador/a
Carmona Asenjo, Ana Teresa Investigador/a
Supuran, Claudio T. Investigador/a
Kato, Atsushi Investigador/a
Merino Montiel, Penelope Investigador/a
Bernardes, Gonçalo Investigador/a
Martínez Montiel, Mónica Investigador/a
Martínez Lara, Rosa Isela Investigador/a
Fratta, Simone Investigador/a
Velueta Viveros, Marta Investigador/a
Pesic, Milica Investigador/a
Carranza César, Marina Contratado
Publicaciones relacionadas
Tipo Año Título Fuente
Artículo 2023 Biotinylated selenocyanates: potent and selective cytostatic agents BIOORGANIC CHEMISTRY
Artículo 2023 Conformationally restricted glycoconjugates derived from arylsulfonamides and coumarins: new families of tumour-associated carbonic anhydrase inhibitors INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Artículo 2023 Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies BIOORGANIC & MEDICINAL CHEMISTRY
Artículo 2023 Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Artículo 2023 N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer's Disease Results in Chemistry
Artículo 2022 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Artículo 2022 A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in C. elegans CHEMICAL COMMUNICATIONS
Artículo 2022 A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE). JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Revisión 2022 Butyrylcholinesterase inhibitors as potential anti-Alzheimer’s agents: an updated patent review (2018-present) EXPERT OPINION ON THERAPEUTIC PATENTS
Artículo 2022 Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease BIOORGANIC CHEMISTRY
Artículo 2022 Chemoselective Preparation of New Families of Phenolic-Organoselenium Hybrids-A Biological Assessment. MOLECULES
Artículo 2022 Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease BIOORGANIC & MEDICINAL CHEMISTRY
Artículo 2022 Functionalized d - And l - no -Pyrrolidines as Potent and Selective Glycosidase Inhibitors SYNTHESIS-STUTTGART
Artículo 2022 Squaramide-tethered sulfonamides and coumarins: synthesis, inhibition of tumor-associated CAs IX and XII and docking simulations INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Artículo 2022 Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Artículo 2022 Structure-based identification and biological characterization of new NAPRT inhibitors PHARMACEUTICALS
Artículo 2022 Survey of new, small-molecule isatin-based oxindole hybrids as multi-targeted drugs for the treatment of Alzheimer’s disease SYNTHESIS-STUTTGART
Nota: la fuente de financiación de las publicaciones se ha obtenido de WOS